Drug Delivery

share

Eagle Pharmaceuticals has announced that the 505(b)(2) New Drug Application (NDA) for its novel ready-to-use bivalirudin product (RTU...

share

Alcyone Lifesciences, a leader in neural intervention systems for neurological conditions and targeted drug delivery, and Lysogene, a...

share

Asahi Kasei Pharma has received approval for its regulatory application from the Japanese Pharmaceutical and Medical Device Agency...

share

US-based Delcath Systems has received orphan drug designation from the US Food and Drug Administration's (FDA) Office of...

share

Rexahn Pharmaceuticals, a clinical stage biopharmaceutical company developing best-in-class therapeutics for the treatment of cancer, announced that it...